Poloxamer 188 failed to prevent exercise-induced membrane breakdown in mdx skeletal muscle fibers

Area of Science:

• Biomedical Engineering
• Muscle Physiology
• Pharmacology

Background:

• Duchenne muscular dystrophy (DMD) is characterized by dystrophin deficiency, leading to muscle membrane instability.
• Poloxamer 188 (P188) has shown promise in protecting cardiac muscle membranes in mdx mice.
• The efficacy of P188 in protecting skeletal muscle membranes remains unclear.

Purpose of the Study:

• To investigate the protective effect of poloxamer 188 (P188) against exercise-induced membrane breaches in dystrophin-deficient (mdx) skeletal muscle fibers.
• To compare the effectiveness of P188 in skeletal muscle versus previously reported effects in cardiac muscle.

Main Methods:

• mdx mice were administered P188 or placebo via intraperitoneal injection.
• Mice underwent treadmill exercise for 60-90 minutes to induce muscle stress.
• Membrane integrity was assessed using in vivo Evans blue dye penetration in rectus femoris muscle cross-sections.

Main Results:

• No significant difference in the percentage of dye-penetrated muscle was observed between the P188 and placebo groups across three trials.
• These findings contrast with prior studies demonstrating P188's protective effects on mdx mouse heart muscle.

Conclusions:

• Poloxamer 188 (P188) did not demonstrate effectiveness in preventing exercise-induced membrane damage in mdx mouse skeletal muscle.
• Potential reasons for this discrepancy include exercise intensity exceeding P188's protective capacity, suboptimal P188 delivery, or fundamental differences between skeletal and cardiac muscle responses to P188 treatment.